Skadden is representing Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, in its merger with QLT Inc., a Canada-based biotechnology company focused on developing orphan ophthalmology products, announced June 26.

BACK TO TOP